Liverpool, United Kingdom

Gemma L Nixon

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gemma L Nixon. Retrieved from https://idiyas.com/inventor/gemma-l-nixon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gemma L Nixon: Innovator in Respiratory Therapeutics

Introduction

Gemma L Nixon is a prominent inventor based in Liverpool, GB. She has made significant contributions to the field of respiratory therapeutics, particularly in the treatment of mycobacterial infections such as tuberculosis. Her innovative approach combines various therapeutic agents to enhance treatment efficacy.

Latest Patents

Gemma holds a patent for a groundbreaking invention titled "Combination of respiratory electron transport chain inhibitors with a cytochrome bd inhibitor." This invention relates to a combination therapeutic product that includes one or more respiratory electron transport chain inhibitors and a cytochrome bd inhibitor, or a pharmaceutically acceptable salt thereof. The patent also covers pharmaceutical compositions that utilize this combination and outlines its application in treating mycobacterial infections.

Career Highlights

Throughout her career, Gemma has demonstrated a strong commitment to advancing medical science. Her work has focused on developing innovative solutions to combat challenging infections, showcasing her dedication to improving patient outcomes.

Collaborations

Gemma has collaborated with notable professionals in her field, including Giancarlo A Biagini and Stephen Andrew Ward. These partnerships have contributed to the development and refinement of her innovative therapeutic approaches.

Conclusion

Gemma L Nixon is a trailblazer in the field of respiratory therapeutics, with her patent representing a significant advancement in the treatment of mycobacterial infections. Her contributions continue to inspire and pave the way for future innovations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…